ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

Ellie Wilcock, 25, first visited her GP in April 2022 after feeling abdominal pain which she initially attributed to a ...

Colorectal cancer is now the leading killer for those under 50. Two individuals have shared their experiences with Newsweek.

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...

TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...

BATAVIA - Kristina Gilbert was taken aback at first after Genesee Cancer Assistance Executive Director Sue Underwood asked ...

In 2021, Kelli Sosa was diagnosed with ovarian cancer. While undergoing chemotherapy and surgeries, doctors determined that ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian ...

If the tests are normal, the likelihood of ovarian cancer is extremely low and other options to manage the symptoms can be ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...